Magnetic resonance imaging in acute myocardial infarction

Current Opinion in Cardiology

Volumn 14, Issue 6, 1999, Pages 480-484

  Wu, Katherine C ^a   Rochitte, Carlos E ^b   Lima, João A C ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HEART INFARCTION; HUMAN; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY;

EID: 0033220237     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199911000-00005     Document Type: Article

References (57)

1. Gruppo Italiano Per Lo Studio Della Streptochinasi Nell'Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986, i:397-401.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction:ISIS-2. Lancet 1988 2:349-360.
3. Grines CL, Browne KF, Marco J, et al.: A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993, 673-679.
4. Gersh BJ, Anderson JL: Thrombolysis and myocardial salvage: results of clinical trials and the animal paradigm-paradox or predictable? Circulation 1993, 88:296-306.
5. Guerci AD, Gerstenblith G, Brinker JA, et al.: A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med 1987, 317:1613-1618.
6. Sheehan FH, Doerr R, Schmidt WG, et al.: Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival. J Am Coll Cardiol 1988, 289-300.
7. Hochman JS, Choo H: Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987, 75:299-306.
8. Lavie CJ, O'Keefe JH, Chesebro JH, Clements IP, Gibbons RJ: Prevention of late ventricular dilatation after acute myocardial infarction by successful thrombolytic reperfusion. Am J Cardiol 1990, 66:31-46.
9. Nidorf SM, Siu SC, Galambos G, Weyman AE, Picard MH: Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J Am Coll Cardiol 1993, 21:683-691.
10. Lincoff AM, Topol EJ: Illusion of reperfusion: does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993, 87:1792-1805.
11. Ito H, Tomooka T, Sakai N, et al.: Lack of myocardial perfusion immediately after successful thrombolysis. Circulation 1992, 85:1699-1705.
12. Kloner RA, Ganote CE, Jennings RB: The "no-reflow" phenomenon after temporary occlusion in the dog. J Clin Invest 1974, 54:1496-1508.
13. Ambrosio G, Weisman HF, Mannisi JA, Becker LC: Progressive impairment of regional myocardial perfusion after restoration of postischemic blood flow. Circulation 1989, 80:1846-1861.
14. Braunwald E, Kloner RA: Myocardial reperfusion: a double-edged sword. J Clin Invest 1985, 76:1713-1719.
15. Braunwald E, Kloner RA: The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982, 66:1146-1149.
16. Bolli R: Mechanism of myocardial "stunning". Circulation 1990, 82:723-738.
17. Marban E: Myocardial stunning and hibernation: the physiology behind the colloquialisms. Circulation 1991, 83:681-688.
18. Fram J, Merboldt KD, Bruhm H, Gyngell ML, Hanicke W, Chien D: A 0.3-second FLASH MRI of the human heart, Magn Reson Med 1990, 13:150-157.
19. Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman R: First-pass nuclear magnetic resonance imaging studies of patients with coronary artery disease. J Am Coll Cardiol 1991, 18:959-965.
20. Goldman MR, Brady TJ, Pykett IL, et al.: Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation 1982, 66:1012-1016.
21. Rochitte CE, Lima JAC, Bluemke DA, et al.: The magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998, 98:1006-1014.
22. Schaeffer S, Malloy CR, Katz J, et al.: Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J Am Coll Cardiol 1988, 12:1064-1072.
23. Judd RM, Lugo-Olivieri CH, Arai M, et al.: Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995, 92:1902-1910.
24. Kim RJ, Chen EL, Lima JAC, Judd RM: Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996, 94:3318-3326.
25. Holman ER, van Jongergen HPW, van Dijkman PRM, van der Laarse A, de Roos A, van der Wall EE: Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size. Am J Cardiol 1993, 71:1036-1040.
26. Lima JAC, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA: Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Circulation 1995, 92:1117-1125.
27. Jennings RB, Murray CE, Steenbergen CJ, Reimer KA: Development of cell injury in sustained acute ischemia. Circulation 1990, 82(suppl II):II2-II12.
28. Saeed M, Wendland MF, Masui T, Higgins CB: Reperfused myocardial infarctions on T1-and susceptibility-enhanced MRI; evidence for loss of compartmentalization of contrast media, Magn Reson Med 1994, 31:31-39.
29. Diesbourg LD, Prato FS, Wisenberg G, et al.: Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992, 23:239-253.
30. Schwitter J, Saeed M, Wendland MF, et al.: Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 1997, 30:1086-1094.
31. Peshock RM, Malloy CR, Buja LM, Nunnally RL, Parkey RW, Willerson JT: Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion. Circulation 1986, 74:1434-1440.
32. Fishbein MC, Meerbaum S, Rit J, et al.: Early phase acute myocardal infarct size quantification: validation of the triphenyl tetrazotium chloride tissue enzyme staining technique. Am Heart J 1981, 101:593-600.
33. Miura T: Does reperfusion induce myocardial necrosis? Circulation 1990, 82:1070-1072.
34. Horneffer PJ, Healy B, Gott VL, Gardner TJ: The rapid evolution of a myocardial infarction in an end-artery preparation. Circulation 1987, 39:V39-42.
35. Wu KC, Zerhouni EA, Judd RM, et al.: The prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998, 97:765-772.
36. Mahmanan JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS: Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol 1995, 25:1333-1340.
37. Asanuma T, Tanabe K, Ochiai K, et al.: Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction. Circulation 1997, 96:448-453.
38. Ragosta M, Camarano G, Kaul S, Powers ER, Sarembock IJ, Gimple IW: Microvascular integrity indicated myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation 1994, 89:2562-2569.
39. Ito H, Okamura A, Iwakura K, et al.: Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996, 93:1993-1999.
40. Schofer J, Montz R, Mathey DG: Scintigraphic evidence of the "no-reflow" phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 1985, 5:593-598.
41. Jeremy RW, Links JM, Becker LC: Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no-reflow phenomenon with positron emission tomography. J Am Coll Cardiol 1990, 16:695-704.
42. Albelda SM, Smith CW, Ward PA: Adhesion molecules and inflammatory injury. FASEB J 1994, 8:504-512.
43. Nathan C, Srimal S, Farber C: Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol 1989, 109:1341-1349.
44. Krug A, De Rochemont WM, Korb G: Blood supply of the myocardium after temporary coronary occlusion, Circ Res 1966, 19:57-62.
45. Wu KC, Kim RJ, Bluemke DA, et al.: Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion [abstract]. J Am Coll Cardiol 1998, 31:201A.
46. Becker LC, Ambrosio G: Myocardial consequences of reperfusion. Prog Cardiovasc Dis 1987, 30:23-44.
47. Ito H, Maruyama A, Iwakura K, et al.: Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996, 93:223-228.
48. Rochitte CE, Melin JA, Bluemke DA, et al.: The extent of microvascular obstruction best predicts left ventricular remodeling after acute myocardial infarction [abstract]. Circulation 1997, 96:1-305.
49. Erlebacher JA, Weiss JL, Eaton LW, Kallman CA, Weisfeldt ML, Bulkley BH: Late effects of acute infarct dilation on heart size: a two-dimensional echocardiographic study. Am J Cardiol 1982, 49:1120-1126.
50. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
51. Kramer CM, Lima JAC, Reichek N, et al.: Regional differences in function within noninfarcted myocardium during left ventricular remodeling. Circulation 1993, 88:1279-1288.
52. Richard V, Murray CE, Reimer KA: Healing of myocardial infarcts in dogs: effects of late reperfusion. Circulation 1995, 92:1891-1901.
53. 23Na magnetic resonance imaging of acute reperfused myocardial infarction: potential to assess myocardial viability. Circulation 1997, 95:1877-1885.
54. Kim RJ, Chen EL, Rochitte CE, Judd RM, Lima JAC: In vivo 23-Na and contrast-enhanced 1-H MRI to assess infarct size after reperfused infarction [abstract]. Circulation 1997, 96:1-305.
55. Judd RM, Parrish TB, Holly TA, et al.: In vivo 3D sodium (23-Na) magnetic resonance imaging in rabbits subject to acute, repertused infarction and human volunteers at 1.5T [abstract]. Circulation 1997, 96:1-305.
56. Manning WJ, Li W, Edelman RR: A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. N Engl J Med 1993, 328:828-832.
57. Clarke GD, Eckels R, Chaney C, et al.: Measurement of absolute epicardial coronary artery flow and flow reserve with breath-hold cine phase-contrast magnetic resonance imaging. Circulation 1995, 91:2627-2634.